Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced key changes ...
Hosted on MSN7h
Stifel Initiates Coverage of Edgewise Therapeutics (EWTX) with Hold Recommendation
Fintel reports that on January 22, 2025, Stifel initiated coverage of Edgewise Therapeutics (NasdaqGS:EWTX) with a Hold ...
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...
Edgewise Therapeutics promotes Behrad Derakhshan to COO
Edgewise Therapeutics (EWTX) announced changes to its executive team. These changes include the addition of Robert Blaustein, joining the ...
Edgewise Therapeutics reshuffles executive team
BOULDER, Colo. - Edgewise Therapeutics Inc. (NASDAQ:EWTX), a biopharmaceutical company focused on muscle disease treatment ...
Le Lézard11h
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
Affinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and other lung diseases, today announced that the ...
Le Lézard12h
Revelation Pharma Strengthens Its Nationwide Presence in ENT and Animal Health with Acquisition of Cascade Specialty Pharmacy
Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies, today announced its acquisition of Washington-based Cascade Specialty Pharmacy. Cascade Specialty Pharmacy brings ...